Drugs / ProSTEM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04357600 | May 2018 → Jun 2027 expected | cirrhosis of liver | PT. Prodia Stem Cell Indonesia | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ProSTEM | “the stem cells in this study were provided from Prodia Stem Cell Indonesia (ProSTEM)” NCT04357600 ↗ |
| Modality | Cell therapy | “allogeneic mesenchymal stem cell therapy” NCT04357600 ↗ |
| Route | Intravenous | “The dosage of the intravenous route is 100 million MSCs for each subject.” NCT04357600 ↗ |